Skip to content
Home
About us
Insights
Stocks
Compliance
Special Services
Contact
Language
EN
BR
EN
EN
BR
Tag:
Oncoclínicas
Insights
Oncoclínicas Seeks Waiver to Avoid Technical Default on Debentures
3 de March de 2026
Insights
Oncoclinicas Cut to ‘CCC-’ as Fitch Flags High Restructuring Risk
26 de February de 2026
Insights
Oncoclínicas Seeks Court Order to Limit BRB’s Influence Over FIPs After CVM Inquiry
30 de January de 2026
Insights
Oncoclínicas Confirms It Hired Consultant to Search for New CEO
9 de January de 2026
Insights
Latache details Jan. 7 board slate and seeks to reshape Oncoclínicas governance
17 de December de 2025
Insights
Oncoclínicas Moves Toward Extraordinary Meeting That Could Oust Entire Board
11 de December de 2025
Insights
Goldman Sachs Cuts Oncoclínicas Exposure to 9% After Capital Increase
27 de November de 2025
Insights
ANS Restores Cancer Care at Oncoclínicas as Unimed Ferj Is Replaced in Emergency Overhaul
27 de November de 2025
Insights
Latache Moves to Oust Oncoclínicas Board in Full Overhaul Push
26 de November de 2025
Insights
Liquidity to Shape the Success of Oncoclínicas’ ‘Back to Basics’ Strategy
22 de November de 2025
←
Previous Page
1
2
3
Next Page
→
